Home
>
National Drug Code (NDC)
>
Ibandronate Sodium
Ibandronate Sodium - 0591-3770-11 - (ibandronate sodium)
Drug Information of Ibandronate Sodium
| Product NDC: | 0591-3770 |
| Proprietary Name: | Ibandronate Sodium |
| Non Proprietary Name: | ibandronate sodium |
| Active Ingredient(s): | 150 mg/1 & nbsp; ibandronate sodium |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Ibandronate Sodium
| Product NDC: | 0591-3770 |
| Labeler Name: | Watson Laboratories, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA079003 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20120320 |
Package Information of Ibandronate Sodium
| Package NDC: | 0591-3770-11 |
| Package Description: | 1 TABLET in 1 BLISTER PACK (0591-3770-11) |
NDC Information of Ibandronate Sodium
| NDC Code | 0591-3770-11 |
| Proprietary Name | Ibandronate Sodium |
| Package Description | 1 TABLET in 1 BLISTER PACK (0591-3770-11) |
| Product NDC | 0591-3770 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | ibandronate sodium |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20120320 |
| Marketing Category Name | ANDA |
| Labeler Name | Watson Laboratories, Inc. |
| Substance Name | IBANDRONATE SODIUM |
| Strength Number | 150 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Bisphosphonate [EPC],Diphosphonates [Chemical/Ingredient] |
